New Drug Data Challenge Ways We Treat Myeloma

In his blog this week, IMF Chairman Dr. Brian Durie reviews the key highlights of the annual meeting of the American Society of Clinical Oncology (ASCO) and the 2015 International Myeloma Working Group (IMWG) Summit. Data from clinical trials of the monoclonal antibodies elotuzumab and daratumumab dominated discussions at both events, and Dr. Durie considers the challenges these new drugs present for how we treat myeloma. Click HERE to read his blog.
Source: International Myeloma Foundation - Category: Hematology Source Type: news